In the News

48753 ksm logo_biz3_1.png

Published on Ynet- Our preprint “Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine”

ynet (In Hebrew)

Sep 3, 2021

48753 ksm logo_biz3_1.png

Published today on Doctorsonly.
Our preprint: "Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections"

Doctorsonly (in Hebrew)

Sep 2, 2021

48753 ksm logo_biz3_1.png

Published today in Science magazine: our preprint "Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine"

Science

September 1, 2021

48753 ksm logo_biz3_1.png

Published today in Science magazine: our preprint "Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections"

Science

Aug 27, 2021

48753 ksm logo_biz3_1.png

New collaboration with Ibex - introducing the world first AI powered solution for gastrointestinal cancer diagnosis at Maccabi Healthcare Services.

AIthority

Aug 25, 2021

48753 ksm logo_biz3_1.png

Nature News new story - our study assessing the correlation between time-from-vaccine and incidence of breakthrough infection in Nature News. We found that Individuals who were vaccinated in January 2021 had a 2.26-fold increased risk for breakthrough infection compared to individuals who were vaccinated in April 2021

Nature.com

Aug 5, 2021

48753 ksm logo_biz3_1.png

Our joint research with Tel Aviv University published in JAMA closed an important knowledge gap on the safety and effectiveness of the COVID-19 vaccine, by examining the pregnant population which was excluded from the clinical trials.

Ynet

July 25, 2021

48753 ksm logo_biz3_1.png

Just published in Reuters Health - Our new study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD)

Reuters Health

July 18, 2021

48753 ksm logo_biz3_1.png

Our study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD), published July 2, 2021 in Gastroenterology—the flagship journal of the American Gastroenterology Association.

Gastroenterolgy

July 2, 2021

48753 ksm logo_biz3_1.png

Published today in Doctorsonly

Linkedin

June 13, 2021

48753 ksm logo_biz3_1.png

KSM study in the New York Times!
Our academia-healthcare collaboration with Technion Institute of Technology appearing in the New York Times.
The study "Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals" just published.

New York Times

June 11, 2021

48753 ksm logo_biz3_1.png

Our joint research with Prof. Roy Kishony and his team from Technion Institute "Community-level evidence for Coronavirus vaccine protection of unvaccinated individuals" published today on Nature Medicine Magazine.

Nature Medicine Magazine

June 10, 2021

48753 ksm logo_biz3_1.png

A new research by KSM shows most respondents are in favor of vaccinating 12-16 year olds— men more in favor than women. Furthermore, new insights on additional vaccine doses, mask usage stats and more are described.

Doctors Only ( In Hebrew).

June 6, 2021

48753 ksm logo_biz3_1.png

New KSM research in association with IBM:
Trends in clinical characteristics of severe non-respiratory events related to Coronavirus patients

Linkedin

Apr 18, 2021

48753 ksm logo_biz3_1.png

Our new survey on behaviour attitudes towards preventive measures following Coronavirus vaccination

Linkedin

Apr 14, 2021

48753 ksm logo_biz3_1.png

A new KSM study shows that the rate of children diagnosed with celiac disease in Israel has increased almost threefold over a decade

Ynet (In Hebrew)

Mar 25, 2021

48753 ksm logo_biz3_1.png

Continuing to monitor vaccinated members - 62 days following the first vaccine dose

Linkedin

Mar 11, 2021

48753 ksm logo_biz3_1.png

Our new study on Coronavirus reinfection published today on DoctorsOnly

Doctors Only (In Hebrew)

Mar 10, 2021

48753 ksm logo_biz3_1.png

KSM is publishing a new real world data study on reinfected Maccabi members

Linkedin

Mar 09, 2021

48753 ksm logo_biz3_1.png

A retrospective analysis of serological data in 116 Israeli healthcare workers administered with the Coronavirus vaccine

Linkedin

Mar 07, 2021